OrphanDrug
OrphanDrug
Pharma Knowledge Base

severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency

ORPHA: 329249

Contents

  1. 1. Overview
  2. 2. Available Treatments
  3. 3. Clinical Presentation
  4. 4. Classification & Codes

Overview

human disease

Available Treatments (0)

No treatments linked yet

Clinical trials or compassionate use may be available — consult a specialist.

Clinical Presentation

Signs and symptoms associated with severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency, sourced from HPO and Orphanet clinical annotations.

HyperinsulinemiaObesityPolyphagiaShort statureReduced social responsivenessAggressive behaviorDelayed speech and language developmentNo social interaction

Classification & Codes

Orphanet Code

ORPHA:329249
severe early-onset obesity-insulin resistance syndrome due to SH2B1 deficiency
OrphanetORPHA:329249
Treatments0 drug(s)
Symptoms on record8 signs
Statuspublished
Factual Authority
Last Updated3/20/2026
Clinical DataHPO · Orphanet
Drug DataFDA · EMA · CDSCO